Walking Impairment Questionnaire in PAD
Terminated
- Conditions
- Peripheral Artery Disease
- Registration Number
- NCT01114178
- Lead Sponsor
- University Hospital, Angers
- Brief Summary
Purpose is to test and validate a new questionnaire (the WELCH questionnaire) to estimate walking capacity in patients with claudication
- Detailed Description
Questionnaires (WELCH and WIQ) submitted to patients referred for treadmill walking test Comparison of sore to MWD on treadmill. Comparison with WIQ will be performed
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 340
Inclusion Criteria
- informed consent signed, french language fluent patients
Exclusion Criteria
- rejection of the questionnaire
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method scoring of the WELCH questionnaire 1 day predetermined score for the WELCH questionnaire answers (4 questions)
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie claudication in peripheral artery disease patients assessed with the WELCH questionnaire?
How does the WELCH questionnaire compare to standard treadmill tests in evaluating walking impairment in PAD patients?
Are there specific biomarkers that correlate with maximal walking distance in peripheral artery disease?
What adverse events are associated with treadmill testing in PAD patients using clinical questionnaires?
What combination therapies have shown effectiveness in improving walking capacity for PAD patients alongside questionnaires?
Trial Locations
- Locations (1)
University Hospital
🇫🇷Angers, France
University Hospital🇫🇷Angers, France